Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-07-16

Clinical Trial Update: Single Patient Compassionate Use / Expanded Access L-S-Gboxin (Lyophilized Form of S-Gboxin) for the Treatment of Diffuse Midline Glioma

View source ↗

Summary

Single-patient compassionate-use/expanded-access study of L-S-Gboxin for diffuse midline glioma is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • L-S-Gboxin (S-Gboxin)

Snippet

Sponsor: Petrov, Andrey | Conditions: DIPG Brain Tumor, Diffuse Brainstem Glioma | Status: NO_LONGER_AVAILABLE